Statin prescribing for people with severe mental illnesses: a staggered cohort study of ‘real-world’ impacts

摘要

ObjectivesTo estimate the ‘real-world effectiveness of statins for primary prevention of cardiovascular disease (CVD) and for lipid modification in people with severe mental illnesses (SMI), including schizophrenia and bipolar disorder.